peoplePerson
Johannes Czernin
Nuclear medicine leader who helped bring PSMA PET and radioligand therapy to the United States.
Nuclear medicine physician and editor-in-chief of the Journal of Nuclear Medicine. Co-led the UCLA/UCSF prospective PSMA PET trials behind FDA approval and the US 177Lu-PSMA-617 experience.
Role
Chief, Ahmanson Translational Theranostics Division, UCLA
Institution
Specialisms
Nuclear medicinePSMA theranosticsPET imaging
Profiles
| Title | Journal | Year |
|---|---|---|
| Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial | JAMA Oncology | 2019 |
| Molecular imaging in the development of cancer therapeutics | Annual Review of Medicine | 2006 |